Clinical trials
Phase 2 Cognitive Dysfunction trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Douglas Mental Health University Institute | 2 |
| Sonexa Therapeutics, Inc. | 2 |
| University of Alberta | 2 |
| AbbVie | 1 |
| Acumen Pharmaceuticals | 1 |
| Allon Therapeutics | 1 |
| Brain and Cognition Discovery Foundation | 1 |
| CHU de Quebec-Universite Laval | 1 |
| Centre for Addiction and Mental Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 19 |
| Alzheimer Disease | 11 |
| Dementia | 8 |
| Tauopathies | 4 |
| Memory Disorders | 3 |
| Pick Disease of the Brain | 3 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Nervous System Diseases | 2 |
| Neurodegenerative Diseases | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.